CD21 antibody (AA 300-590)
Quick Overview for CD21 antibody (AA 300-590) (ABIN6138992)
Target
See all CD21 (CR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 300-590
-
Sequence
- IVTYTCDPDP EEGVNFILIG ESTLRCTVDS QKTGTWSGPA PRCELSTSAV QCPHPQILRG RMVSGQKDRY TYNDTVIFAC MFGFTLKGSK QIRCNAQGTW EPSAPVCEKE CQAPPNILNG QKEDRHMVRF DPGTSIKYSC NPGYVLVGEE SIQCTSEGVW TPPVPQCKVA ACEATGRQLL TKPQHQFVRP DVNSSCGEGY KLSGSVYQEC QGTIPWFMEI RLCKEITCPP PPVIYNGAHT GSSLEDFPYG TTVTYTCNPG PERGVEFSLI GESTIRCTSN DQERGTWSGP A
-
Cross-Reactivity
- Human, Mouse, Rat
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 300-590 of human CR2/CD21 (NP_001006659.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000,IHC,1:50 - 1:100,IF,1:50 - 1:100
-
Comment
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))
-
Alternative Name
- CR2
-
Background
- This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.,CR2,C3DR,CD21,CR,CVID7,SLEB9,Immunology & Inflammation,CD markers,CR2
-
Molecular Weight
- 110 kDa/112 kDa/118 kDa/119 kDa
-
Gene ID
- 1380
-
UniProt
- P20023
-
Pathways
- Complement System
Target
-